Delayed Xetra 5-day change 1st Jan Change
- EUR -.--% Intraday chart for TELES -.--% +67.63%

Financials

Sales 2022 1.92M 2.06M 163M Sales 2023 59.28M 63.55M 5.02B Capitalization 8.35M 8.95M 707M
Net income 2022 -1M -1.07M -84.69M Net income 2023 -2M -2.14M -169M EV / Sales 2022 12.6 x
Net cash position 2022 41.98K 45.01K 3.56M Net Debt 2023 11.06M 11.85M 936M EV / Sales 2023 0.33 x
P/E ratio 2022
-14.3 x
P/E ratio 2023
-2.9 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 26.91%
More Fundamentals * Assessed data
Dynamic Chart
TELES Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
TELES Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
TELES AG Informationstechnologien Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
TELES AG Informationstechnologien Reports Earnings Results for the Full Year Ended December 31, 2021 CI
TELES AG Informationstechnologien Auditor Raises 'Going Concern' Doubt CI
TELES AG Informationstechnologien Provides Sales Guidance for the Year 2022 CI
TELES AG Informationstechnologien acquired unknown majority stake in EURO RX Arzneimittel GmbH. CI
TELES AG Informationstechnologien acquired an unknown majority stake in Gvl Rechenzentrum Gmbh. CI
TELES AG Informationstechnologien Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
Managers TitleAgeSince
Chief Executive Officer - 12-31
Members of the board TitleAgeSince
Chairman - 26/10/16
Director/Board Member - 11/08/19
Director/Board Member - 11/08/19
More insiders
Teles AG is a Germany-based company, formerly known as TELES Informationstechnologien AG. It operates in the pharmaceutical and telecommunications segments. The Company provide services that cover the entire spectrum from analysis of existing infrastructure, requirements and the regulatory framework through investment consulting and development of custom solutions. It helps customers with the configuration, implementation and migration of a new infrastructure solution. The Company's product portfolio comprises Softclients & Mobile Apps that allow users to be reachable via fixed line using computers, tables, mobile phones or office phones. The Company also offers voice application servers and Softswitches for Internet Protocol (IP) networks. In the core business of pharmaceuticals, the focus is on the supply of prescription drugs with a digitized supply chain. Drugs for cancer, autoimmune deficits and combination therapies for personalized medicine are delivered throughout Europe.
Calendar
More about the company